Aridis Pharmaceuticals, Inc.
(NASDAQ : ARDS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.15%129.870.7%$918.44m
PFEPfizer Inc.
0.37%36.640.9%$720.28m
MRKMerck & Co., Inc.
0.32%82.770.7%$597.44m
ABBVAbbVie, Inc.
-0.55%71.212.3%$549.43m
BMYBristol-Myers Squibb Company
0.25%49.861.4%$446.95m
LLYEli Lilly and Company
0.86%112.081.0%$328.05m
AZNAstraZeneca PLC Sponsored ADR
1.16%43.631.2%$144.77m
NVSNovartis AG Sponsored ADR
-0.10%86.440.2%$132.31m
GSKGlaxoSmithKline plc Sponsored ADR
0.12%41.150.3%$82.28m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.04%50.950.1%$69.33m
SNYSanofi Sponsored ADR
0.16%44.370.2%$54.20m
LCILannett Company, Inc.
-0.73%13.6735.6%$51.50m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.99%1.971.6%$2.19m
EPIXESSA Pharma Inc
2.21%3.010.1%$0.19m

Company Profile

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-105, AR-101, AR-401, AR-201, and AR-501. The company was founded by Eric J. Patzer and Vu L. Truong in 2003 and is headquartered in San Jose, CA.